Courtside with the Chair: Discussion on 2025 Sports Eligibility Guidelines - Part 1
“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Aaron Baggish, Benjamin Levine, and Matthew Martinez to take a deep dive into the recently released 2025 Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology. Subscribe to CardiaCast | Claim CME Credit
--------
23:55
Heart Vision: Use of Stress CMR for Evaluation of Microvascular Dysfunction
“Heart Vision” is a CardiaCast podcast series produced by the ACC Cardiovascular Imaging Section Leadership Council. This podcast series tackles topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort. In this episode, Drs. Purvi Parwani and Michael Salerno discuss how stress cardiovascular magnetic resonance (CMR) is transforming the way we understand and diagnose coronary microvascular dysfunction. We will also discuss the noninvasive comparison of the stress CMR with stress positron emission tomography (PET) for evaluation of myocardial perfusion reserve index, its clinical applications and practical usage. Dr. Salerno will shed light on how this innovative imaging technique is offering new insights into the pathophysiology of the microvasculature, guiding the diagnosis, and ultimately improving patient outcomes through the correct diagnosis.
--------
17:38
Decision Makers: Crafting Personalized AFib Care with a Team Approach
In this podcast, which is part of the AFib Management Redefined: Latest Guidelines For Care of the Patient With Atrial Fibrillation grant initiative, Andrea Price, MS, AACC hosts Brooke Gonzales, RN, Elena Wellen PharmD, BCCP, Megan Herrington, PA-C, AACC and Meena Rao, MD, MPH, FACC in a multidisciplinary discussion highlighting the 2023 Guideline updates and the importance of a patient centered cardiac care team approach to AFib diagnosis, management, and treatment. The conversation will focus on interprofessional collaboration and how to tailor care based on individual patient characteristics and preferences. This podcast is part of the AFib Management Redefined: Latest Guidelines For Care of the Patient With Atrial Fibrillation grant initiative. Educational grant support is provided by Abbott Laboratories, Biosense Webster, Boston Scientific Corporation, and Janssen Scientific Affairs. Click here for more: https://learn.acc.org/Page/LearnAFibGuidelines Atrial Fibrillation Focused Update | Journal of the American College of Cardiology 2023 Atrial Fibrillation Guideline-at-a-Glance | JACC
--------
22:58
Conversations with Critical Care Cardiologists: Advanced Education and Training in CCC
In this episode of Conversations with Critical Care Cardiologists, we dive into the evolving landscape of education and training in Critical Care Cardiology (CCC). As this specialty rapidly advances, what cognitive competencies should be prioritized? How do procedural skills fit into the equation? And who holds the responsibility for defining and standardizing these competencies? Join us as we explore the future of CCC training, the role of medical societies, and strategies for ensuring consistency and excellence in education—both within CCC and across the broader field of cardiology. Subscribe to CardiaCast |
--------
21:19
Innovation in Action: Training AI Screening of Cardiac Amyloidosis
“Innovation in Action” is a new podcast series hosted by the American College of Cardiology’s (ACC) Innovation Program aimed to explore innovations shaping care delivery. In this first episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by Drs. Amey Vrudhula and Lily Stern to delve into artificial intelligence (AI) model training and how to leverage AI for early screening of cardiac amyloidosis. This podcast is supported by AstraZeneca. Related References: Vrudhula A, Stern L, Cheng PC, et al. Impact of case and control selection on training artificial intelligence screening of cardiac amyloidosis. JACC Adv 2024;3:100998. Subscribe to CardiaCast | Claim CME Credit
This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.
Brasil